UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5045, 09/2013, Volume 10, Issue 9, pp. 553 - 562
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Morbidity - trends | Global Health | Humans | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - epidemiology | DNA, Viral - genetics | Disease Progression | Causes of | Genetic aspects | Research | Hepatitis C | Epidemiology | Distribution | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 08/2015, Volume 163, Issue 3, pp. 215 - 223
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Costs | Insurance, Health, Reimbursement | Medicaid - economics | Antiviral Agents - therapeutic use | United States | Humans | Uridine Monophosphate - economics | Hepatitis C, Chronic - drug therapy | Uridine Monophosphate - analogs & derivatives | Antiviral Agents - economics | Eligibility Determination | Health Policy | Sofosbuvir | Uridine Monophosphate - therapeutic use | Care and treatment | Medicaid | Hepatitis C | Analysis | Drugs | Hepatitis | Infections | Index Medicus | Abridged Index Medicus
Journal Article
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5045, 11/2017, Volume 14, Issue 11, pp. 641 - 651
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hepatitis C - psychology | Substance Abuse, Intravenous | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Drugs | Antiviral agents | Opioids | Clinical trials | Chronic infection | Infections | Interferon | Index Medicus
Journal Article
Antiviral research, ISSN 0166-3542, 04/2014, Volume 104, Issue 1, pp. 62 - 72
Drug users | Treatment as prevention | HCV | IDUs | Injection | PWID | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Antiviral agents | Drug addiction | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Viral diseases | Biological and medical sciences | Medical sciences | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Addictive behaviors | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Global Health | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Seroepidemiologic Studies | Antibodies, Viral - blood | Substance-Related Disorders - complications | Substance-Related Disorders - epidemiology | Cost-Benefit Analysis | Hepatitis C - epidemiology | Geography, Medical | Hepatitis C - complications | Hepatitis C - prevention & control | Hepacivirus | Index Medicus
Journal Article
Journal of hepatology, ISSN 0168-8278, 12/2017, Volume 67, Issue 6, pp. 1204 - 1212
Recurrence | Hepatocellular carcinoma | Chronic hepatitis C virus | Occurrence | Epidemiology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Neoplasms - virology | Antiviral Agents - therapeutic use | Humans | Middle Aged | Male | Risk | Carcinoma, Hepatocellular - virology | Interferons - therapeutic use | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Liver Neoplasms - etiology | Female | Aged | Carcinoma, Hepatocellular - etiology | Liver cancer | Hepatitis | Cirrhosis | Interferon | Hepatitis C | Antiviral drugs | Patients | Risk factors | Meta-analysis | Index Medicus
Journal Article
The International journal of drug policy, ISSN 0955-3959, 2015, Volume 26, Issue 1, pp. S22 - S26
Internal Medicine | Medical Education | Hepatitis C | PWID | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Drug Costs | Needle-Exchange Programs - organization & administration | Prevalence | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Cost of Illness | Hepatitis C - economics | Health Services Accessibility | Antiviral Agents - adverse effects | Harm Reduction | Hepatitis C - epidemiology | Opiate Substitution Treatment - methods | Health Policy | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Virus diseases | Antiviral agents | Health care reform | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Disease prevention | Hepatitis | Antiretroviral drugs | Injections | Human immunodeficiency virus--HIV | Health care access | Public health | Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 3/2013, Volume 207, Issue 1, pp. S19 - S25
hepatitis C virus | human immunodeficiency virus | treatment | barriers | coinfection | drug users | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Infections - prevention & control | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Coinfection - prevention & control | Humans | Infection Control - methods | Hepatitis C - diagnosis | HIV Infections - diagnosis | HIV Infections - complications | Coinfection - diagnosis | HIV Infections - drug therapy | Hepatitis C - complications | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Index Medicus | Abridged Index Medicus | Hepatitis C Virus-HIV Co-Infection
Journal Article